| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Marta Colletti | Q56863270 |
| P2093 | author name string | Luigi Di Luigi | |
| Sabino Scolletta | |||
| Clara Crescioli | |||
| P2860 | cites work | Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes | Q46942111 |
| Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis | Q47353546 | ||
| Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. | Q51973496 | ||
| 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. | Q54118701 | ||
| Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. | Q54793731 | ||
| A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia | Q57351169 | ||
| SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS | Q58205027 | ||
| Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target | Q59813820 | ||
| 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro | Q67280107 | ||
| The role of monocytes and T cells in 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro | Q67957412 | ||
| 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages | Q69664632 | ||
| 1 alpha,25-Dihydroxyvitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro | Q69802550 | ||
| An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 | Q24303828 | ||
| Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells | Q24307649 | ||
| Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes | Q24336187 | ||
| Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients | Q24563395 | ||
| The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions | Q24564834 | ||
| Requirement of the chemokine receptor CXCR3 for acute allograft rejection | Q24676298 | ||
| A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis | Q24804035 | ||
| Vitamin D and colon cancer | Q27027710 | ||
| 1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes | Q70161320 | ||
| Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations | Q70336407 | ||
| Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency | Q70488328 | ||
| Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific | Q71114381 | ||
| MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat | Q71878976 | ||
| Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice | Q72177828 | ||
| MC 1288--a vitamin D analogue with immunosuppressive effects on heart and small bowel grafts | Q72566987 | ||
| Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060 | Q72572312 | ||
| Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants | Q73832066 | ||
| Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A | Q74013224 | ||
| Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia | Q74024194 | ||
| The regulatory effects of all-trans-retinoic acid on isotype switching: retinoic acid induces IgA switch rearrangement in cooperation with IL-5 and inhibits IgG1 switching | Q74583047 | ||
| Receptors for 1alpha,25(OH)2D3: past, present, and future | Q77301816 | ||
| Vitamin D3: a transcriptional modulator of the interferon-gamma gene | Q77530666 | ||
| Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization | Q77647010 | ||
| Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism | Q77800973 | ||
| Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) | Q79314633 | ||
| Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop | Q79346423 | ||
| Novel insights in the immune function of the vitamin D system: synergism with interferon-beta | Q79664824 | ||
| Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: implication for assessment of disease activity and treatment | Q81475298 | ||
| Vitamin D and diabetes | Q81877790 | ||
| The vitamin D analog TX527 ameliorates disease symptoms in a chemically induced model of inflammatory bowel disease | Q87352281 | ||
| Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection | Q94028922 | ||
| Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs. | Q46740652 | ||
| CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation | Q46844200 | ||
| Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. | Q46886748 | ||
| Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis | Q46936670 | ||
| The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
| NF-kappaB regulation in the immune system | Q28205043 | ||
| Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes | Q28251802 | ||
| Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy | Q28258849 | ||
| 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 | ||
| A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. | Q33205503 | ||
| Inhibition of acute and chronic allograft rejection in mouse models by BXL-628, a nonhypercalcemic vitamin D receptor agonist | Q33218425 | ||
| Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. | Q33219961 | ||
| Prevention of chronic allograft rejection by Vitamin D receptor agonists | Q33220675 | ||
| 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. | Q33606850 | ||
| The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). | Q33888800 | ||
| Expression of chemokines and chemokine receptors during human renal transplant rejection | Q33936064 | ||
| Vitamin effects on the immune system: vitamins A and D take centre stage | Q34005584 | ||
| Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature | Q34164524 | ||
| 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis | Q34251340 | ||
| Calcipotriol ointment. A review of its use in the management of psoriasis | Q34436374 | ||
| Vitamin D: its role and uses in immunology | Q34451101 | ||
| Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
| Transpleural gradient of 1,25-dihydroxyvitamin D in tuberculous pleuritis | Q34572129 | ||
| The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents | Q34583816 | ||
| Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol) | Q34617856 | ||
| 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes | Q34624558 | ||
| The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury | Q35031907 | ||
| Vitamin D in preventive medicine: are we ignoring the evidence? | Q35117137 | ||
| Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3 | Q35462970 | ||
| Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression | Q35538137 | ||
| Vitamin D and breast cancer | Q35705253 | ||
| Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection | Q35842094 | ||
| The fate of bone after renal transplantation | Q35855604 | ||
| Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. | Q36066638 | ||
| Intervention in autoimmunity: the potential of vitamin D receptor agonists | Q36152308 | ||
| Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts | Q36208185 | ||
| Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo | Q36236655 | ||
| Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells | Q36313495 | ||
| Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). | Q36353962 | ||
| Donor-derived IP-10 initiates development of acute allograft rejection | Q36369253 | ||
| Vitamin D receptor agonists: opportunities and challenges in drug discovery | Q36539572 | ||
| Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor | Q36555534 | ||
| Primary and secondary prevention of Type 1 diabetes | Q36631971 | ||
| Role of chemokines in endocrine autoimmune diseases | Q36809557 | ||
| 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells | Q36993676 | ||
| Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. | Q37073695 | ||
| 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism | Q37348815 | ||
| Vitamin D nutritional policy needs a vision for the future | Q37776370 | ||
| Effects of vitamin D on the peripheral adaptive immune system: a review | Q37881236 | ||
| Vitamin D3: a helpful immuno-modulator | Q37927252 | ||
| CXCL10: a candidate biomarker in transplantation. | Q37988245 | ||
| Investigation of hypercalcemia | Q38008558 | ||
| Molecular aspects of vitamin D anticancer activity | Q38042081 | ||
| The role of the vitamin D endocrine system in health and disease | Q38611160 | ||
| Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells | Q39957476 | ||
| Structure-function relationships in the vitamin D endocrine system | Q40545127 | ||
| Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells | Q40760687 | ||
| Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages | Q40887948 | ||
| 24,25-dihydroxyvitamin D3 suppresses the rapid actions of 1, 25-dihydroxyvitamin D3 and parathyroid hormone on calcium transport in chick intestine | Q42476960 | ||
| Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia | Q42497305 | ||
| Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol | Q42505016 | ||
| gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages | Q42527804 | ||
| Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. | Q42538603 | ||
| Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. | Q42645407 | ||
| Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes | Q43077082 | ||
| Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system | Q43123528 | ||
| Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells. | Q43123671 | ||
| Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotoic liver transplantation | Q43186258 | ||
| Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation | Q43620821 | ||
| A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice | Q43620842 | ||
| 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts | Q43779213 | ||
| 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants | Q43850962 | ||
| The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol | Q43914153 | ||
| A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice | Q43972530 | ||
| 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells | Q44060028 | ||
| A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function | Q44181048 | ||
| Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells | Q44448880 | ||
| Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. | Q44580641 | ||
| 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis | Q44853183 | ||
| 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR | Q45269262 | ||
| Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol | Q46050394 | ||
| Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells | Q46241666 | ||
| Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. | Q46677379 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | intracellular receptor | Q117980 |
| peptide | Q172847 | ||
| vitamin D | Q175621 | ||
| anti-inflammatory agent | Q581996 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 876319 | |
| P577 | publication date | 2013-04-17 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation | |
| P478 | volume | 2013 |
| Q58797423 | Association of low skeletal muscle index with increased systematic inflammatory responses and interferon γ-induced protein 10 levels in patients with colon cancer |
| Q36238175 | CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats |
| Q100526063 | Early-pregnancy transcriptome signatures of preeclampsia: from peripheral blood to placenta |
| Q90725695 | Editorial: Chemokines and Bone |
| Q39317665 | Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis |
| Q90050058 | Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers |
| Q36301100 | Mycobacterial infection induces a specific human innate immune response |
| Q33666631 | No evidence for an association of vitamin D deficiency and migraine: a systematic review of the literature |
| Q37718362 | PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach |
| Q36460566 | Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications |
| Q89511653 | Pleiotropic Biological Effects of Dietary Phenolic Compounds and their Metabolites on Energy Metabolism, Inflammation and Aging |
| Q50739158 | Profiling of selenium absorption and accumulation in healthy subjects after prolonged L-selenomethionine supplementation. |
| Q98292008 | Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies |
| Q92652930 | Serum Vitamin D Metabolites and CXCL10 Concentrations Associate With Survival in Dogs With Immune Mediated Disease |
| Q59791331 | Sex- and Development-Dependent Responses of Rat Microglia to Pro- and Anti-inflammatory Stimulation |
| Q36435673 | Silymarin Suppresses Cellular Inflammation By Inducing Reparative Stress Signaling |
| Q38884582 | Sport and male sexuality |
| Q89597077 | Targeting Age-Dependent Functional and Metabolic Decline of Human Skeletal Muscle: The Geroprotective Role of Exercise, Myokine IL-6, and Vitamin D |
| Q38784181 | Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells |
| Q58556795 | The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence |
| Q39107994 | The relation of innate and adaptive immunity with viral-induced acute asthma attacks: Focusing on IP-10 and cathelicidin |
| Q35035562 | The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies |
| Q33892454 | Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse. |
| Q26780466 | Update in vitamin D and multiple sclerosis |
| Q38837175 | Vitamin D and autoimmunity |
| Q57806359 | Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma |
| Q26849424 | Vitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathy |
Search more.